The prognosis of cancer of the endometrium depends on the type of tumour. It is usually low grade with a good prognosis. In some cases, it can mimic the symptoms of progestational changes. However, there are some risk factors that can affect the prognosis of patients with cancer of the endometrium. Listed below are some risk factors to watch for. These risk factors can help you determine the right treatment for you.
Age, tumor stage, and the presence of risk factors are considered traditional prognostic factors. The presence of steroid hormone receptors may predict the response to progestin therapy. The survival rates of stage I, II, and III cancers are 81%, 64%, and 40%, respectively. Survival rates for stage IV cancer are 18%. Statistical analysis was performed using Stata 13.1 software. This research provides more accurate information regarding the prognosis of cancer of the endometrium and other types of cancer.
Endometrial cancer has a poor prognosis. The incidence of cancer of the endometrium has remained stable in industrialized countries in recent decades. It is usually diagnosed by atypical uterine bleeding during postmenopausal women. The five-year overall survival rate is 81.7 percent and varies from 20 to 91% for different histologies. Radiologists must incorporate histopathologic subtypes I or II in their reporting. The risk factors and clinical features of the two subtypes are shown in Figures I and II.
Among women with endometrial cancer, the risk of developing bowel cancer is high. If you are a Lynch syndrome patient, the risk of developing other cancers can be reduced with treatment. The National Institute for Health and Care Excellence recommends Lynch syndrome screening for patients with endometrial cancer. You can consult a genetic counselor for a consultation about the risk factors for cancer of the endometrium.
The study’s authors concluded that estrogen-related tumors were more likely to recur in older women than in younger women. They noted that cigarette smoking reduced the risk of developing endometrial cancer, but increased the risk in women who had menopause at the time of diagnosis. The authors concluded that the risk of developing cancer of the endometrium was low and that it was not related to menopausal symptoms.
To diagnose cancer of the endometrium, your doctor may perform an endometrial biopsy. This procedure involves inserting a thin tube into the womb and scraping a small portion of endometrium tissue. The samples are then examined under a microscope for evidence of cancer cells. A similar procedure, called dilatation and curettage (D&C), is used to remove tissue from the lining of the uterus.
MRI is a powerful imaging tool and is recommended by the American College of Radiology for patients with endometrial cancer. It provides vital information for pretreatment risk stratification and the selection of paraaortic lymph nodes. However, radiologists must be aware of the differences in imaging and clinical features of the two main types of endometrial cancer. Furthermore, advanced techniques improve the accuracy of MRI imaging and alert to high-risk lymph node metastasis.
